Tiemann Investment Advisors, LLC Edwards Lifesciences Corp Transaction History

Tiemann Investment Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$72.54 - $95.56 $168,655 - $222,177	2,325 New	2,325 $222,000
Q2 2023 Aug 11, 2023	BUY	$81.41 - $94.33 $172,996 - $200,451	2,125 New	2,125 $200,000
Q2 2022 Aug 12, 2022	BUY	$86.5 - $128.27 $4,325 - $6,413	50 Added 2.53%	2,025 $193,000
Q3 2021 Nov 15, 2021	SELL	$102.91 - $122.75 $22,640 - $27,005	-220 Reduced 10.02%	1,975 $224,000
Q2 2021 Aug 13, 2021	BUY	$83.84 - $104.76 $102,955 - $128,645	1,228 Added 126.99%	2,195 $227,000
Q1 2021 May 11, 2021	SELL	$78.68 - $90.67 $106,060 - $122,223	-1,348 Reduced 58.23%	967 $207,000
Q4 2020 Feb 16, 2021	SELL	$71.69 - $91.23 $17,922 - $22,807	-250 Reduced 9.75%	2,315 $211,000
Q3 2020 Nov 12, 2020	BUY	$67.19 - $87.44 $172,342 - $224,283	2,565 New	2,565 $205,000

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Tiemann Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Tiemann Investment Advisors, LLC with notifications on news.